Differential expression of metallothionein and p21 in gastric cancer and some precursor lesions

Bibliographic Information
Authors: Helal N.S.; Moussa M.M.; Aboushousha T.; Aboul-Ezz M.A.; Magdy M.
Journal: European Review for Medical and Pharmacological Sciences
Publisher: Verduci Editore s.r.l
Publication Date: 2022
Volume / Issue: Volume 26 / Issue 9
Pages: 3100–3108
ISSN: 11283602
DOI: 10.26355/eurrev_202205_28727
Scopus: View on Scopus
PubMed: 35587060
Document Type: Article
Authors and Affiliations
Helal N.S., Department of Pathology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Moussa M.M., Department of Pathology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Aboushousha T., Department of Pathology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Aboul-Ezz M.A., Department of Hepatology and Gastroenterology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Magdy M., Department of Pathology, Theodor Bilharz Research Institute (TBRI), Giza, Egypt
Abstract
OBJECTIVE: Gastric cancer (GC) is a heterogeneous disease with molecular diversity between and within tumors; therefore, searching for altered genes within this cancer is mandatory to reach the proper individualized targeted therapy. Expressions of Metallothionein (MT) and p21 are not uniform in various types of cancers and their predictive value in GC is controversial. This study aimed to assess the role of MT and p21 in intestinal-type GC and some of its precursor lesions. MATERIALS AND METHODS: Immunohistochemical staining for MT and p21 was applied on paraffin blocks belonging to 30 GCs and 51 benign gastric lesions/precancerous lesions [33 chronic gastritis and 18 chronic gastritis with gastric intestinal metaplasia (GIM)]; 27 of them were associated with H. pylori infection. RESULTS: MT expression was dramatically increased while p21 expression was dramatically decreased from chronic gastritis to GIM to GC. In precancerous lesions, H. pylori-positive cases had significantly higher MT expression and lower p21 expression compared to H. pylori-negative cases. In GCs, decreased expression of both MT and p21 was associated with high-grade and advanced-stage cancers. CONCLUSIONS: Both MT and p21 may have a role in the development and progression of GC, and both proteins may be useful for selecting targeted therapy for GC patients. © 2022 Verduci Editore s.r.l. All rights reserved.
Keywords
Gastric cancer; H. pylori; Intestinal metaplasia; MT; p21; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metallothionein; Metaplasia; Precancerous Conditions; Stomach Neoplasms; paraffin; protein p21; adult; Article; cancer grading; cancer staging; chronic gastritis; controlled study; disease association; female; Helicobacter infection; human; human cell; immunohistochemistry; major clinical study; male; middle aged; precancer; protein expression; stomach cancer; stomach carcinogenesis; stomach tissue; complication; genetics; metabolism; pathology; stomach mucosa; stomach tumor
Citation Information
Scopus Citations: 8
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
